Sucrose-Formulated Octocog Alfa: A Review of its Use in Patients with Haemophilia A

Author： Frampton James E.   Wagstaff Antona J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.6, 2008-01, pp. : 839-853

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octocog Alfa, Antihaemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate®): A Review of its Use in the Management of Patients with Haemophilia A

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 987-1007

Adis International

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX

By Lyseng-Williamson Katherine A.   Plosker Greg L.  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1007-1029

Adis International

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital or Acquired Haemophilia and Other Congenital Bleeding Disorders

By Siddiqui M. Asif A.   Scott Lesley J.  

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1161-1177

Adis International

Access to resources Recommend Favorite

Octocog alfa has haemostatic efficacy in young children with severe haemophilia A

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Darbepoetin Alfa: A Review of its Use in the Treatment of Anaemia in Patients with Cancer Receiving Chemotherapy

By Siddiqui M. Asif A.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 997-1012

Adis International

Access to resources Recommend Favorite